442903-28-8

Basic information

• Product Name: 3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester
• Synonyms: 3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester;4-dichloropyridine-3-carboxylate;2,4-Dichloro nicotinic acid Methyl ester;Methyl 2,4-dichloropyridine-3-carboxylate;Methyl 2,4-dichloropyridine-3-carboxylate, 2,4-Dichloro-3-(methoxycarbonyl)pyridine;2,4-dichloro-, Methyl ester;2,4-Dichloro-3-pyridinecarboxylic acid methyl ester
• CAS NO: 442903-28-8
• Molecular Formula: C₇H₅Cl₂NO₂
• Molecular Weight: 206.0261
• Mol File: 442903-28-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 266.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.426±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -1.24±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester(442903-28-8)
• EPA Substance Registry System: 3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester(442903-28-8)

Safety Data

• Hazardous Substances Data: 442903-28-8(Hazardous Substances Data)

Usage

General Description

3-Pyridinecarboxylic acid, 2,4-dichloro-, Methyl ester is a chemical compound, also known by its systematic name Methyl 2,4-dichloronicotinate. It falls into the category of organonitrogen compounds, specifically, pyridines and derivatives. As the name suggests, it is a methyl ester, meaning it's derived from an acid (in this case 3-Pyridinecarboxylic acid) by replacing a hydrogen in the acid with a methyl group. Furthermore, it is a dichloro compound, indicating the presence of two chlorine atoms. The exact characteristics, properties, and potential uses of this chemical are subject to study and can vary based on its interactions with other substances.

InChI:InChI=1S/C7H5Cl2NO2/c1-12-7(11)5-4(8)2-3-10-6(5)9/h2-3H,1H3

Upstream product

• 262423-77-8 2,4-dichloronicotinic acid 
• 74-88-4 methyl iodide 
• 26452-80-2 2,4-dichloropyridine 

Relevant articles and documents

HEMOGLOBIN MODIFIER COMPOUNDS AND USES THEREOF

Described herein are compounds, including pharmaceutically acceptable salts thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat, prevent or diagnose blood-based diseases, disorders or conditions.

Aryl vinyllactam serinekinase inhibitor

The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.

PYRIDO [4,3-d] PYRIMIDIN-4 (3H) -ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS

The present invention is directed to novel pyrido[4,3-d]pyrimidin-4(3H)-one derivatives and pharmaceutically acceptable salts thereof of structural formula I wherein the variables R1, R2, R3, R4 and R5 are as described herein. Also provided are pharmaceutical compositions comprising the compounds of formula I as well as methods of treatment employing compounds of formula I to treat a disease or disorder characterized by abnormal bone or mineral homeostasis such as hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy.